BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹3.11 | ₹4.79 | ₹2.21 | ₹2.46 | ₹-7.94 |
What is the latest Earnings Per Share (EPS) of BAFNA PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹3.11 |
| Mar2024 | ₹4.79 |
| Mar2023 | ₹2.21 |
| Mar2022 | ₹2.46 |
| Mar2021 | ₹-7.94 |
How is Earnings Per Share (EPS) of BAFNA PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.11 | -35.07 | |
| Mar2024 | ₹4.79 | 116.74 | |
| Mar2023 | ₹2.21 | -10.16 | |
| Mar2022 | ₹2.46 | Positive | |
| Mar2021 | ₹-7.94 | - | |
Compare Earnings Per Share (EPS) of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹532.3 Cr | 8.2% | 49.6% | 193.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 8.2% |
49.6% |
193.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses